?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
October 9, 2019
signalgroup
The Biosimilars Forum Applauds Congressmen Paul Tonko (D-NY) and Bob Gibbs (R-OH) for Introducing Legislation Mandating a CMS Star Ratings Program for Biosimilars
News
October 3, 2019
signalgroup
President Trump Can Easily Reduce Health Care Costs for U.S. Seniors and Taxpayers by Increasing Biosimilar Use
News
October 3, 2019
signalgroup
New Analysis Confirms All 50 States Stand to Benefit from Increased Use of Biosimilars
News
October 1, 2019
signalgroup
The Biosimilars Forum Applauds Congressmen Scott Peters, Pete King and Anthony Brindisi For Introducing $0 Copay Biosimilars Legislation for Medicare Part B
News
September 20, 2019
signalgroup
The Biosimilars Forum Applauds Bipartisan Introduction of the BIOSIM Act
News
September 19, 2019
signalgroup
House Energy & Commerce Committee Hearing Highlights How Biosimilars Can Save Patients Money
News
September 9, 2019
Katie Quinn
Biosimilars Forum’s Public Letter In Response to Anti-Biosimilars Op-Ed
News
August 22, 2019
Katie Quinn
New Analysis Encourages Employer Engagement to Help Realize Significant Savings Potential of Biosimilars
News
July 30, 2019
Katie Quinn
Forum Statement in Response to Senate Finance Committee Advancing its Drug Pricing Package
News
July 25, 2019
Katie Quinn
Forum Statement on Senate Finance Provision and New Amendment That Could Save Taxpayers and Seniors Billions
Prev page
11
12
13
14
15
Next page